lyell syndrome - HEALTHIES
Learn about Lyell and how we are building an industry-leading clinical-stage pipeline of CAR-T cell product candidates for cancer. Lyell is a fully-integrated company combining science, research, and manufacturing to advance CAR T-cell product candidates. Learn more.
Understanding the Context
Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma Learn about life at Lyell, our values, and how we are united in our mission to advance next‑generation cell therapies for patients with cancer. Lyell is committed to developing safe and effective CAR T-cell therapies for patients with cancer. Our goal is to provide our therapies to patients in a timely and clinically appropriate manner. Additionally, cell therapies are made through highly complex manufacturing processes which Lyell performs at our LyFE Manufacturing Center™.
Image Gallery
Key Insights
Tennessean: Publishing exec, abuse survivor Jen Lyell remembered as Southern Baptist Convention meets Jennifer Lyell, a former executive for Lifeway, the SBC's publishing arm, also became known for advocating for abuse reform in the denomination after coming forward with her own account. Lyell helped ...